Karel A. Van Dort

Amsterdam, NH 1105AZ, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Blocking Host Factors IAP and DDX3 Activates HIV-1 Transcription and Increases Apoptosis Sensitivity of HIV-1 Infected Cells.

Blocking Host Factors IAP and DDX3 Activates HIV-1 Transcription and Increases Apoptosis Sensitivity of HIV-1 Infected Cells.

Journal: Pathogens (Basel, Switzerland)
Published: February 16, 2026

HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation is associated with the subsequent reduction in the viral reservoir.

HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation is associated with the subsequent reduction in the viral reservoir.

Journal: eLife
Published: January 23, 2026

Treatment in acute HIV infection only temporarily preserves monocyte function: a comparative cohort study in adult males.

Treatment in acute HIV infection only temporarily preserves monocyte function: a comparative cohort study in adult males.

Journal: EBioMedicine
Published: March 27, 2025

Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9.

Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9.

Journal: iScience
Published: April 29, 2024

Human Immunodeficiency Virus-Induced Interferon-Stimulated Gene Expression Is Associated With Monocyte Activation and Predicts Viral Load.

Human Immunodeficiency Virus-Induced Interferon-Stimulated Gene Expression Is Associated With Monocyte Activation and Predicts Viral Load.

Journal: Open forum infectious diseases
Published: March 27, 2024

A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals.

A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals.

Journal: The Journal of infectious diseases
Published: February 21, 2024

Long-term effect of temporary ART initiated during primary HIV-1 infection on viral persistence.

Long-term effect of temporary ART initiated during primary HIV-1 infection on viral persistence.

Journal: Nature communications
Published: February 16, 2024

Energy demanding RNA and protein metabolism drive dysfunctionality of HIV-specific T cell changes during chronic HIV infection.

Energy demanding RNA and protein metabolism drive dysfunctionality of HIV-specific T cell changes during chronic HIV infection.

Journal: PloS one
Published: January 24, 2024

Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection.

Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection.

Journal: AIDS (London, England)
Published: September 13, 2023

A genetic variation in fucosyltransferase 8 accelerates HIV-1 disease progression indicating a role for N-glycan fucosylation.

A genetic variation in fucosyltransferase 8 accelerates HIV-1 disease progression indicating a role for N-glycan fucosylation.

Journal: AIDS (London, England)
Published: August 20, 2023

Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV.

Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV.

Journal: Microbiology spectrum
Published: May 11, 2023

25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations.

25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations.

Journal: Vaccine
Published: March 10, 2023
Showing 1-12 of 40

Last Updated: 09/26/2026